GSK N 35, Moscow Oblast

Economic indicators

Net profit (RAS) of GSK N 35 over 2023 was the same as in 2022 reaching 48.00 thousand RUB, the company informed.

Revenue remained in the accounting period at the same level and made up 804.00 thousand RUB compared to 804.00 thousand RUB 804.00 thousand RUB; sales profit matched the previous year’s result amounting to 48.00 thousand RUB.

Net profit (RAS) of GSK N 35 over 2022 was the same as in 2021 reaching 48.00 thousand RUB, the company informed.

Revenue remained in the accounting period at the same level and made up 804.00 thousand RUB compared to 804.00 thousand RUB 804.00 thousand RUB; sales profit matched the previous year’s result amounting to 48.00 thousand RUB.

Net profit (RAS) of GSK N 35 grew over 2021 by 2.13% to 48.00 thousand RUB from 47.00 thousand RUB over 2020, the company informed.

Revenue increased in the accounting period by 1.52% to 804.00 thousand RUB from 792.00 thousand RUB over 2020; sales profit went up by 2.13% to 48.00 thousand RUB from 47.00 thousand RUB.

Net profit (RAS) of GSK N 35 dropped in 2020 by 2.08% to 47.00 thousand RUB from 48.00 thousand RUB over the same period in 2019, the company informed.

Revenue decreased in the accounting period by 1.49% to 792.00 thousand RUB from 804.00 thousand RUB in 2019; sales profit fell by 2.08% to 47.00 thousand RUB from 48.00 thousand RUB.

Net profit (RAS) of GSK N 35 over 2019 was the same as in 2018 reaching 48.00 thousand RUB, the company informed.

Revenue remained in the accounting period at the same level and made up 804.00 thousand RUB compared to 804.00 thousand RUB 804.00 thousand RUB; sales profit matched the previous year’s result amounting to 48.00 thousand RUB.

Companies in the region

• Krest'yanskoe khozyaystvo "ROSSIYA"
• SOGDIANA
• NOVYE TEKHNOLOGII
• AKTIV'
• MONIAL